Sophiris Bio Inc fka SPHS

[The Market Maker]

http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001437749-15-002538%2Etxt&FilePath=%5C2015%5C02%5C12%5C&CoName=SOPHIRIS+BIO+INC%2E&FormType=424B3&RcvdDate=2%2F12%2F2015&pdf=


Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.


Nasdaq stated in its January 29th letter that, in accordance with Marketplace Rule 5810(c)(3)(A), the Company has been provided a grace period of 180 calendar days, or until July 28, 2015, to regain compliance with the minimum consolidated closing bid price requirement for continued listing. Compliance will be regained if the Company’s consolidated closing bid price is at or above $1.00 for at least 10 consecutive trading days anytime during the 180-day grace period.

The Company is considering actions that it may take in response to this notification in order to regain compliance with the continued listing requirements.